UnknownNot Applicable

Early Intervention With Therapeutic Exercise in Plantar Fasciopathy

Spain60 participantsStarted 2024-05-10

Plain-language summary

The aim of this project is to evaluate the efficacy of a therapeutic exercise programme in patients with plantar fasciitis applied early and aimed at strengthening the hip and foot musculature.

Who can participate

Age range18 Years – 120 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with referred pain in the medial plantar area of the heel, accentuated with initial steps after a period of inactivity but also worsening after prolonged body weight bearing, of at least 3 months evolution prior to inclusion in the study. * Reproduction of the pain referred by the patient with palpation at the proximal insertion of the plantar fascia. Exclusion Criteria: * Pregnancy. * Injection of corticoids in the area in the 6 months prior to recruitment. * Previous illnesses that may alter gait (central or peripheral neurological pathology, degenerative and inflammatory arthropathies, systemic illnesses). * Existence of concomitant foot pathology (metatarsalgia, stress fractures, neuropathies due to entrapment, tendinitis, history of foot/ankle surgery, etc.). * People who do not have the capacity to understand and follow an exercise programme.

What they're measuring

Pain intensity

Timeframe: It will be assessed at baseline and at 12 weeks (at the end of the intervention period), with a subsequent follow-up period at 3 and 6 months after the end of the intervention.

Disability

Timeframe: It will be assessed at baseline and at 12 weeks (at the end of the intervention period), with a subsequent follow-up period at 3 and 6 months after the end of the intervention.

General health and health-related quality of life:

Timeframe: It will be assessed at baseline and at 12 weeks (at the end of the intervention period), with a subsequent follow-up period at 3 and 6 months after the end of the intervention.

Physical activity

Timeframe: It will be assessed at baseline and at 12 weeks (at the end of the intervention period), with a subsequent follow-up period at 3 and 6 months after the end of the intervention.

Overall perception of clinical change

Timeframe: It will be assessed at baseline and at 12 weeks (at the end of the intervention period), with a subsequent follow-up period at 3 and 6 months after the end of the intervention.

Trial details

NCT IDNCT06394336

SponsorUniversidad Miguel Hernandez de Elche

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-05-10

Contact for this trial

Javier Marco, PhD

34 965 919405 jmarco@umh.es

View on ClinicalTrials.gov More Plantar Fascitis trials

Who can participate

Age range18 Years – 120 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Pain intensity

Timeframe: It will be assessed at baseline and at 12 weeks (at the end of the intervention period), with a subsequent follow-up period at 3 and 6 months after the end of the intervention.

Disability

Timeframe: It will be assessed at baseline and at 12 weeks (at the end of the intervention period), with a subsequent follow-up period at 3 and 6 months after the end of the intervention.

General health and health-related quality of life:

Timeframe: It will be assessed at baseline and at 12 weeks (at the end of the intervention period), with a subsequent follow-up period at 3 and 6 months after the end of the intervention.

Physical activity

Timeframe: It will be assessed at baseline and at 12 weeks (at the end of the intervention period), with a subsequent follow-up period at 3 and 6 months after the end of the intervention.

Overall perception of clinical change

Timeframe: It will be assessed at baseline and at 12 weeks (at the end of the intervention period), with a subsequent follow-up period at 3 and 6 months after the end of the intervention.